The bill amends the Public Health Service Act to reauthorize sickle cell disease(SCD) research, surveillance, prevention and treatment. It also aims to establish full funding for twenty-five (25) Sickle Cell Treatment Centers throughout the US. H.R. 1807 requires continued authorization for community-based organization (CBO) collaborative programs to improve medical and support services delivered to affected individuals, and expanded eligibility beyond Federally Qualified Health Centers (FQHC). The bill will provide a better quality of life for an estimated 90,000 individuals in the US who have SCD; and another 3 million trait carriers. This Bill will prevent sickle cell sufferers from traveling hundreds of miles for basic health care and save lives in many unfunded and remote areas.
This is historical material “frozen in time”. The website is no longer updated and links to external websites and some internal pages may not work.
